21st Century Fox Inc (FOXA) Pops 2.59% for February 10

Equities Staff |

One of the S&P 500’s big winners for Wednesday February 10 was 21st Century Fox Inc (FOXA) as the company’s stock climbed 2.59% to $24.76 on volume of 19.96 million shares.

The stock opened at $23.90 and saw an intraday low of $23.38 and an intraday high of $25.11. All told, the day saw a per-share gain of $0.625. The stock’s average daily volume of 12.42 million and 1.22 billion shares outstanding. 21st Century Fox Inc now has a 50-day SMA is $27.05 and 200-day SMA is $29.85, and it has a 52-week high of $35.85 and a 52-week low of $22.66.

Twenty-First Century Fox Inc is a diversified media and entertainment company. It operates in five business segments: Cable Network Programming, Television, Filmed Entertainment, and Other Corporate and Eliminations.

Based out of New York, NY, 21st Century Fox Inc has 20,500 employees and, after today’s trading, reached a market cap of $30.23 billion. The stock’s P/E Ratio is 20.5. Its P/S ratio is 1.11, P/B ratio is 3.19, and P/FCF ratio is -29.5.

For a complete fundamental analysis analysis of 21st Century Fox Inc, check out Equities.com’s Stock Valuation Analysis report for FOXA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…